PHILADELPHIA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industryleading drug discovery, preclinical development, manufacturing and testing solutions provider, today announced a collaboration to demonstrate the benefits of Ori's next-generation CGT manufacturing platform, IRO®(eeRO). In early 2024, Ori and Charles River collaborated through Ori's LightSpeed Early Acc ...